bis(2-guanidinoethyl)disulfide has been researched along with Alloxan Diabetes in 1 studies
bis(2-guanidinoethyl)disulfide: bifunctional cation; RN given refers to parent cpd; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mabley, JG | 1 |
| Southan, GJ | 1 |
| Salzman, AL | 1 |
| Szabó, C | 1 |
1 other study available for bis(2-guanidinoethyl)disulfide and Alloxan Diabetes
| Article | Year |
|---|---|
The combined inducible nitric oxide synthase inhibitor and free radical scavenger guanidinoethyldisulfide prevents multiple low-dose streptozotocin-induced diabetes in vivo and interleukin-1beta-induced suppression of islet insulin secretion in vitro.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Enzyme Inhibit | 2004 |